Bariatric surgery significantly reduced major adverse liver outcomes in MASH cirrhosis

At 15 years of follow-up, metabolic surgery “was not only safe” but also significantly reduced major adverse liver outcomes and decompensation in patients with metabolic dysfunction-associated steatohepatitis and compensated cirrhosis.“Previous studies suggested excellent clinical outcomes in patients with MASH and fibrosis stages 1 to 3 with improvement in both cardiac and

Related Keywords

Arizona , United States , Heather Biele , Bymonica Stonehill , Naim Alkhouri , Arizona Liver Health , Cleveland Clinical Health System , Advancing Long Term ,